DAVITA INC (DVA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for DVA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| DVA | Chief Executive Officer | 55 | ["CEO of DaVita Inc. since June 2019","Joined DaVita in 1998","Experience in operations, payor contracting, and finance","Served on the board of directors of Gilead Sciences, Inc. since June 2020","Deep healthcare expertise and regulatory landscape knowledge"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| GILD | Chief Executive Officer, DaVita; Director | 55 | ["Significant leadership experience in the healthcare industry, including serving as chief executive officer and in various other executive roles of a Fortune 500 public healthcare company", "Recognized for his vision and leadership in transforming how kidney care is delivered and accelerating the digital transformation to improve patients\u2019 lives while lowering costs for the healthcare system", "Audit committee financial expert"] | ["Audit Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Javier J. Rodriguez , 54, has served as the DaVita Inc. CEO since June 2019. From March 2014 until June 2019, he served as the CEO of DaVita Kidney Care. Since joining the Company in 1998, Mr. Rodriguez has served in a number of different capacities. From February 2012 to March 2014, he served as our President. From April 2006 through February 2012, he served as our Senior Vice President. From 2000 to 2006 he served as a Vice President of Operations and Payor Contracting. Mr. Rodriguez joined the Company in 1998 as a Director of Value Management. Prior to joining the Company, Mr. Rodriguez worked for Baxter Healthcare Corporation in Finance from 1995 to 1996. Since June 2020, Mr. Rodriguez has been a member of the Board of Directors of Gilead Sciences, Inc., a research-based pharmaceutical company. Mr. Rodriguez provides extensive knowledge of the healthcare and dialysis industries, and our business, regulatory environment and operations as well as significant executive leadership and management experience.